Arline Faustin

Arline Faustin

Auto-generated profile, based on publicly available information

Arline Faustin

Department of Pathology, NYU Langone Health and NYU Grossman School of Medicine , New York, NY

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 May 2021 in Neurology
Verified
Journal Article
Open access
PDF file
DLDominique F. Leitner
Dominique F. Leitner
JMJames D. Mills
James D. Mills
GPGeoffrey Pires
Geoffrey Pires
AFArline Faustin
Arline Faustin
Eleanor DrummondEleanor Drummond
Eleanor Drummond
ODOrrin Devinsky
Orrin Devinsky
Objective To identify the molecular signaling pathways underlying sudden unexpected death in epilepsy (SUDEP) and high-risk SUDEP compared to control patients with epilepsy. Methods For proteomics analyses, we evaluated the hippocampus and frontal cortex from microdissected postmortem brain tissue of 12 patients with SUDEP and 14 with non-SUDEP epilepsy. For transcriptomics analyses, we evaluated hippocampus and temporal cortex surgical brain tissue from patients with mesial temporal lobe epilepsy: 6 low-risk and 8 high-risk SUDEP as determined by a short (<50 seconds) or prolonged (≥50 seconds) postictal generalized EEG suppression (PGES) that may indicate severely depressed brain activity impairing respiration, arousal, and protective reflexes. Results In autopsy hippocampus and cortex, we observed no proteomic differences between patients with SUDEP and those with non-SUDEP epilepsy, contrasting with our previously reported robust differences between epilepsy and controls without epilepsy. Transcriptomics in hippocampus and cortex from patients with surgical epilepsy segregated by PGES identified 55 differentially expressed genes (37 protein-coding, 15 long noncoding RNAs, 3 pending) in hippocampus. Conclusion The SUDEP proteome and high-risk SUDEP transcriptome were similar to those in other patients with epilepsy in hippocampus and cortex, consistent with diverse epilepsy syndromes and comorbid conditions associated with SUDEP. Studies with larger cohorts and different epilepsy syndromes, as well as additional anatomic regions, may identify molecular mechanisms of SUDEP.

13 June 2019 in American Journal of Neuroradiology
Verified
Journal Article
Open access
PDF file
MHM.J. Hoch
M.J. Hoch
MBMary Bruno
Mary Bruno
AFA. Faustin
A. Faustin
NCN. Cruz
N. Cruz
AMA.Y. Mogilner
A.Y. Mogilner
TST.M. Shepherd
T.M. Shepherd
BACKGROUND AND PURPOSE: The basal forebrain contains multiple structures of great interest to emerging functional neurosurgery applications, yet many neuroradiologists are unfamiliar with this neuroanatomy because it is not resolved with current clinical MR imaging. MATERIALS AND METHODS: We applied an optimized TSE T2 sequence to washed whole postmortem brain samples (n = 13) to demonstrate and characterize the detailed anatomy of the basal forebrain using a clinical 3T MR imaging scanner. We measured the size of selected internal myelinated pathways and measured subthalamic nucleus size, oblique orientation, and position relative to the intercommissural point. RESULTS: We identified most basal ganglia and diencephalon structures using serial axial, coronal, and sagittal planes relative to the intercommissural plane. Specific oblique image orientations demonstrated the positions and anatomic relationships for selected structures of interest to functional neurosurgery. We observed only 0.2- to 0.3-mm right-left differences in the anteroposterior and superoinferior length of the subthalamic nucleus (P = .084 and .047, respectively). Individual variability for the subthalamic nucleus was greatest for angulation within the sagittal plane (range, 15°–37°), transverse dimension (range, 2–6.7 mm), and most inferior border (range, 4–7 mm below the intercommissural plane). CONCLUSIONS: Direct identification of basal forebrain structures in multiple planes using the TSE T2 sequence makes this challenging neuroanatomy more accessible to practicing neuroradiologists. This protocol can be used to better define individual variations relevant to functional neurosurgical targeting and validate/complement advanced MR imaging methods being developed for direct visualization of these structures in living patients.

31 January 2019 in American Journal of Neuroradiology
Verified
Journal Article
Open access
PDF file
MHM.J. Hoch
M.J. Hoch
MBMary Bruno
Mary Bruno
AFA. Faustin
A. Faustin
NCN. Cruz
N. Cruz
LCL. Crandall
L. Crandall
TST.M. Shepherd
T.M. Shepherd
BACKGROUND AND PURPOSE: The brain stem is compactly organized with life-sustaining sensorimotor and autonomic structures that can be affected by numerous pathologies but can be difficult to resolve on conventional MR imaging. MATERIALS AND METHODS: We applied an optimized TSE T2 sequence to washed postmortem brain samples to reveal exquisite and reproducible brain stem anatomic MR imaging contrast comparable with histologic atlases. This resource-efficient approach can be performed across multiple whole-brain samples with relatively short acquisition times (2 hours per imaging plane) using clinical 3T MR imaging systems. RESULTS: We identified most brain stem structures at 7 canonical axial levels. Multiplanar or oblique planes illustrate the 3D course and spatial relationships of major brain stem white matter pathways. Measurements of the relative position, course, and cross-sectional area of these pathways across multiple samples allow estimation of pathway location in other samples or clinical subjects. Possible structure-function asymmetries in these pathways will require further study—that is, the cross-sectional area of the left corticospinal tract in the midpons appeared 20% larger (n = 13 brains, P < .10). CONCLUSIONS: Compared with traditional atlases, multiplanar MR imaging contrast has advantages for learning and retaining brain stem anatomy for clinicians and trainees. Direct TSE MR imaging sequence discrimination of brain stem anatomy can help validate other MR imaging contrasts, such as diffusion tractography, or serve as a structural template for extracting quantitative MR imaging data in future postmortem investigations.

28 November 2024 in Journal of Neuropathology & Experimental Neurology
Verified
Journal Article
Open access
AWAdam Walker
Adam Walker
CFCamila S Fang
Camila S Fang
CSChanel Schroff
Chanel Schroff
JSJonathan Serrano
Jonathan Serrano
VVVarshini Vasudevaraja
Varshini Vasudevaraja
MSMatija Snuderl
Matija Snuderl
Cancer of unknown primary (CUP) constitutes between 2% and 5% of human malignancies and is among the most common causes of cancer death in the United States. Brain metastases are often the first clinical presentation of CUP; despite extensive pathological and imaging studies, 20%-45% of CUP are never assigned a primary site. DNA methylation array profiling is a reliable method for tumor classification but tumor-type-specific classifier development requires many reference samples. This is difficult to accomplish for CUP as many cases are never assigned a specific diagnosis. Recent studies identified subsets of methylation quantitative trait loci (mQTLs) unique to specific organs, which could help increase classifier accuracy while requiring fewer samples. We performed a retrospective genome-wide methylation analysis of 759 carcinoma samples from formalin-fixed paraffin-embedded tissue samples using Illumina EPIC array. Utilizing mQTL specific for breast, lung, ovarian/gynecologic, colon, kidney, or testis (BLOCKT) (185k total probes), we developed a deep learning-based methylation classifier that achieved 93.12% average accuracy and 93.04% average F1-score across a 10-fold validation for BLOCKT organs. Our findings indicate that our organ-based DNA methylation classifier can assist pathologists in identifying the site of origin, providing oncologists insight on a diagnosis to administer appropriate therapy, improving patient outcomes.

28 July 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
DLDominique F. Leitner
Dominique F. Leitner
JMJames D. Mills
James D. Mills
GPGeoffrey Pires
Geoffrey Pires
AFArline Faustin
Arline Faustin
Eleanor DrummondEleanor Drummond
Eleanor Drummond
ODOrrin Devinsky
Orrin Devinsky
Sudden unexpected death in epilepsy (SUDEP) is the leading type of epilepsy-related death. Severely depressed brain activity in these cases may impair respiration, arousal, and protective reflexes, occurring as a prolonged postictal generalized EEG suppression (PGES) and resulting in a high-risk for SUDEP. In autopsy hippocampus and cortex, we observed no proteomic differences between SUDEP and epilepsy cases, contrasting our previously reported robust differences between epilepsy and controls. Transcriptomics in hippocampus and cortex from surgical epilepsy cases segregated by PGES identified 55 differentially expressed genes (37 protein-coding, 15 lncRNAs, three pending) in hippocampus. Overall, the SUDEP proteome and high-risk SUDEP transcriptome largely reflected other epilepsy cases in the brain regions analyzed, consistent with diverse epilepsy syndromes and comorbidities associated with SUDEP. Thus, studies with larger cohorts and different epilepsy syndromes, as well as additional anatomic regions may identify molecular mechanisms of SUDEP.

25 December 2023 in Alzheimer's & Dementia
Verified
Journal Article
Open access
MTManon Thierry
Manon Thierry
JPJackeline Ponce
Jackeline Ponce
MAMitchell Marta Ariza
Mitchell Marta Ariza
MAManor Askenazi
Manor Askenazi
AFArline Faustin
Arline Faustin
Thomas WisniewskiThomas Wisniewski
Thomas Wisniewski
Background: APOE polymorphism is the major genetic risk factor for sporadic Alzheimer’s disease (AD), characterized by the abnormal accumulation of β‐amyloid (Aβ) and phosphorylated Tau (pTau). Although the various ApoE isoforms are known mostly to differentially modulate Aβ aggregation and clearance, recent data support an influence of APOE genotype on pTau accumulation, which correlates better with AD symptom progression. The exact effects of ApoE isoforms on pTau metabolism, however, remain unclear.Method: The localized proteomic methods developed in our laboratory, on post‐mortem human brain, are an ideal strategy to elucidate these aspects de novo. Co‐immunopurifications (IP) against pTau pSer396/pSer404 (PHF1) from frozen frontal cortex were combined with mass spectrometry to map out, for the first time, the pTau interactome across APOE genotypes in 10 sporadic AD cases (n = 5 APOEε3/ε3 and n = 5 APOEε4/ε4).Result: A total of 1130 and 1330 proteins were enriched in the IPPHF1 samples of the APOEε3/ε3 and APOEε4/ε4 groups (FC ≥ 1.50, IPPHF1 vs. IPIgG ctrl) and represented respectively 62% and 70% of the proteins previously identified as bona fide pTau interactors, validating our approach (Drummond et al., 2020). We identified 184 and 176 proteins as bona fide pTau interactors in the APOEε3/ε3 and APOEε4/ε4 groups (SAINT scores ≥ 0.65). Only 79 pTau interactors were common to both APOE groups and were mostly involved in proteostasis pathways (ubiquitin‐proteasome system, RNA metabolism, endo‐lysosomal trafficking). The pTau interactome of the APOEε3/ε3 group contained 17 proteins upregulated in APOEε3/ε3 cases (FC ≥ 1.50, IPPHF1 (APOEε3/ε3) vs. IPPHF1 (APOEε4/ε4))), a large majority of which being involved in RNA binding, processing or splicing (13/17 proteins, STRING analysis). The pTau interactome of the APOEε4/ε4 group contained 33 proteins upregulated in APOEε4/ε4 cases (FC ≥ 1.50, IPPHF1 (APOEε4/ε4) vs. IPPHF1 (APOEε3/ε3))), most of them being involved in synaptic transmission pathways (16/33 proteins, STRING analysis).Conclusion: Our proteomic data highlighted an influence of the APOE polymorphism on pTau metabolism. These results will be validated in the human brain using histological and biochemical methods, paving the way to the identification of new therapeutic targets for AD.